You are not authorized to access this page.
Search Within

Jeffrey Girshman

Formats
  1. Journal Article (19)
  2. Meeting Abstract (9)
  3. Review (3)
Groups
  1. Body Imaging Service (31)
  2. Radiology, Department of (31)
  3. Department of Medicine (25)
  4. Solid Tumor Oncology Division (22)
  5. Epidemiology and Biostatistics (17)
  6. Biostatistics Service (16)

More Groups

People
  1. Carol Aghajanian (12)
  2. Rachel Grisham (11)
  3. Alexia Iasonos (10)
  4. Roisin O'Cearbhaill (8)
  5. Andrew Plodkowski (7)
  6. Qin Zhou (7)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (3)
  4. 2022 (6)
  5. 2021 (7)
  6. 2020 (4)

More Years

Publications
  1. Gynecologic Oncology (4)
  2. International Journal of Gynecological Cancer (3)
  3. Journal of Clinical Oncology (3)
  4. Clinical Cancer Research (2)
  5. Clinical Imaging (2)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. Elsevier Inc. (9)
  2. American Society of Clinical Oncology (5)
  3. Lippincott Williams & Wilkins (5)
  4. American Association for Cancer Research (3)
  5. Mary Ann Liebert, Inc (2)
  6. Springer (2)

More Publishers

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-treatment CT imaging in stage IIIA lung cancer: Can we predict local recurrence after definitive chemoradiotherapy?
    Journal Article

    Plodkowski, A. J.; Araujo-Filho, J. A. B.; Simmers, C. D. A.; Girshman, J.; Raj, M.; Zheng, J.; Rimner, A.; Ginsberg, M. S.
    Clinical Imaging (2021)

    Fulltext@MSK | Save
  • Basket study of the oral progesterone antagonist onapristone ER in women with progesterone receptor positive (PR plus ) recurrent granulosa cell tumor (GCT), low-grade serous ovarian cancer (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Iasonos, A.; Girshman, J.; Cadoo, K. A.; Kyi, C.; Makker, V.; Cohen, S. M.; O'Cearbhaill, R. E.; Sabbatini, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent high-grade and low-grade serous ovarian cancer
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; McDonnell, A.; Iasonos, A.; Zhou, Q.; Li, K.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Aghajanian, C.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Imaging of novel oncologic treatments in lung cancer part 2: Local ablative therapies
    Review

    Halpenny, D.; O'Dwyer, E.; Camacho Vasquez, J.; Shaverdian, N.; Girshman, J.; Ginsberg, M. S.
    Journal of Thoracic Imaging (2020)

    Fulltext@MSK | Save
  • Imaging of novel oncologic treatments in lung cancer part 1: Systemic therapies
    Review

    Halpenny, D.; O'Dwyer, E.; Girshman, J.; Ginsberg, M. S.
    Journal of Thoracic Imaging (2020)

    Fulltext@MSK | Save
  • Harmonization of tumor mutational burden quantification and association with response to immune checkpoint blockade in non-small-cell lung cancer
    Journal Article

    Vokes, N. I.; Liu, D.; Ricciuti, B.; Jimenez-Aguilar, E.; Rizvi, H.; Dietlein, F.; He, M. X.; Margolis, C. A.; Elmarakeby, H. A.; Girshman, J.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: Final results
    Meeting Abstract

    Grisham, R.; Giri, D.; Henson, M.; Iasonos, A.; Zhou, Q.; McDonnell, A.; Girshman, J.; O'Cearbhaill, R.; Zamarin, D.; Aghajanian, C.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Ultrasound guided fine needle aspiration of thyroid: inadequacy rate with rapid on-site evaluation
    Meeting Abstract

    Sebastiano, C.; Lin, O.; Girshman, J.; Buonocore, D.; Cohen, J.
    Virchows Archiv (2019)

    Fulltext@MSK | Save
  • Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib
    Journal Article

    Schoenfeld, A. J.; Arbour, K. C.; Rizvi, H.; Iqbal, A. N.; Gadgeel, S. M.; Girshman, J.; Kris, M. G.; Riely, G. J.; Yu, H. A.; Hellmann, M. D.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save